Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
/in Dendritic Cells, International Publications /von 2015-04-17 / Eur. J. Immunol. 2015 Jun;45(6):1783-93Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2015-04-14 / Chonnam Med J 2015 Apr;51(1):1-7Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
/in Dendritic Cells, International Publications /von 2015-04-12 / Cancer Immunol. Immunother. 2015 Jul;64(7):831-42Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2015-04-02 / Science 2015 May;348(6236):803-8Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity
/in Dendritic Cells, HIV/AIDS, International Publications /von 2015-03-27 / PLoS Pathog. 2015 Mar;11(3):e1004752Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2015-03-17 / Biol. Pharm. Bull. 2015;38(6):827-35Cancer immunotherapy: dendritic-cell vaccines on the move
/in Dendritic Cells, International Publications /von 2015-03-11 / Nature 2015 Mar;519(7543):300-1A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells
/in Dendritic Cells, International Publications /von 2015-03-10 / Oncotarget 2015 Mar;6(7):5195-203Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-03-09 / Cancer Sci. 2015 Apr;106(4):397-406
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de